• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

IVD in China

$3,995.00 – $7,990.00

Clear
SKU: KLI15654332 Categories: Diagnostics Market Research, Immunoassays, Point-of-Care Diagnostics Pages: 138
  • Description
  • Table of Contents
  • Latest reports

Description

IVD in China


As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging.

This report provides the following market data:

  • Market by Province (Guangdong, Shangdong, Henan, Sichuan, Jiangsu, Hebei, Hunan, Anhui, Zhejiang, Others)
  • Market by Rural/Urban
  • Company Profiles
  • Chinese Disease Statistics

Specific Market Data include the following segments:

  • China General Chemistries Market
  • China Blood Gases Testing Market
  • China Urinalysis Testing Market
  • China POC Glucose Market
  • China POC Infectious Disease Market
  • China POC Other Market
  • China Infectious Disease Immunoassay Market
  • China Blood Bank Immunoassay Market
  • China Other Diseases Immunoassay Market
  • China Molecular Microbiology Market
  • China Blood Bank Molecular Market
  • China HPV Molecular Market
  • China Cancer Molecular Market
  • China Other Molecular Market
  • China ID/AST Market
  • China Molecular Microbiology Market
  • China HPV Testing Market
  • China CTC Testing Market
  • China Other Histology/Cytology Market

 

As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. China as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over the past decade – Brazil, Russia and India; collectively with China referred to as one of the important, rapidly growing “BRIC” nations.
 
Situation in China
China offers a large market opportunity but much of this potential remains untapped. With one fifth of the world’s population, it is the second largest clinical laboratory market in Asia and one of the world’s fastest growing. But by world standards, the healthcare system needs modernization and expansion to serve rural populations. Even in the major cities, most residents cannot afford healthcare.
In the last 30 years, the rate of Chinese economic growth has been impressive, averaging 8% – 10% growth in GDP per year. The economy has grown more than 10 times during that 30-year period, with China’s GDP now exceeding $9 trillion. Most analysts project that based on these GDP measures, China will become the largest economy in the world by mid 21st century. However, China’s state spending on health has failed to keep up with its booming economy. In 2006, China’s government health expenditure was less than 1% of GDP, ranking China 156th out of 196 countries surveyed by the WHO. While this has expanded in recent years, the amount is still minimal considering the size of the population and the huge gap to be filled. Furthermore, government spending has tended to favor urban populations; according to the WHO, only 25% of public-health money was devoted to rural areas, home to roughly 57% of the population.
China also suffers from a significant shortage of trained physicians. In 2017, the China Ministry of Health estimated that there were approximately 1.7 doctors per 1,000 people, a number that has not shown any significant change since the early 2000s. Nationwide, about 17% of public hospital medical staff members had a bachelor’s or graduate degree. In village and township hospitals, just 2.2% had a university education, according to health ministry exhibits. China has recently embarked on some reforms to start narrowing that gap. As part of the reforms, more independence was granted to hospitals, of which there are more than 65,000 throughout the country. This meant that healthcare officials at the local levels and hospital managers had more authority than before. There are currently about 1,200 private and public hospitals that serve the wealthy, mostly government employees and company insured. These state-of-the-art Class 1 hospitals are always looking to upgrade. Another 6,800 Class 2 private and public hospitals have engaged in slow modernization efforts as part of the reform plan. About 40,000 township health centers now offer very rudimentary diagnostics, which are also showing signs of improvements and upgrades as a result of the reforms. Still underserved are 150,000 privately-run village clinics that offer almost no services except those such as blood pressure, thermometer and pregnancy tests.
This hospital and clinic infrastructure is supported by at least 18,000 hospital-based labs. They help support hospital services that have been cut in order to help fund expansion into rural areas. There are very few private laboratories or reference labs in China. It is estimated that private labs account for 1% – 5% of the IVD testing in China, but they are very aggressive and offer sophisticated testing not generally available in hospital labs. Currently, only the top-tier of hospitals has the resources to buy the type of clinical laboratory equipment used in developed countries.
In April 2009, the State Council, China’s cabinet, announced $120-billion-plus initial phase of a 10-year plan to improve the country’s healthcare system. Included in the plan is the construction of a medical clinic in every village and at least one hospital in every county. China also pledged to expand medical insurance: government subsidies for insurance premiums aim to extend at least basic coverage to 90% or more of China’s 1.4 billion people.
Since county-level hospitals cater to more than 900 million individuals, developing these hospitals will lead to a recognizable difference in the nation’s health. In 2017, the IVD market in China was estimated at $3,200 million and is expected to show annual growth of 13.2% to reach $5,955 million in 2022. Supporting growth will be a modernizing healthcare infrastructure and steady migration from manual to automated processes.
IVD market growth in China will remain considerably higher than in the mature markets of U.S. and Western Europe, offering a significant opportunity to manufacturers able to work within the Chinese infrastructure. Through the foreseeable future, China will continue to offer one of the fastest growing markets for IVD products, even for western-style lab instrumentation and advanced tests outside of the scope of recent public healthcare network expansion.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

INTRODUCTION

Figure 1-1: Market Drivers and Restraints: IVD Market in China

SCOPE AND METHODOLOGY

MAJOR FINDINGS OF THE REPORT

IVD MARKET IN CHINA

Figure 1-2: China IVD Market, 2017 and 2022 ($ millions)

CHAPTER TWO: CHINA IN CONTEXT

OVERVIEW

Figure 2-1 : China IVD Market vs. China Medical Device Market, 2017-2022

Figure 2-2 : China Market Dynamics

POPULATION TRENDS

Table 2-1: Total Midyear Population by Broad Age Group: China (million persons), 2010-2050

Figure 2-3 : Total Midyear Population by Broad Age Group: China (million persons), 2010-2050

Figure 2-4: Total Number of Births in China by Year, 1990-2010 and Forecast 2020-2050

Figure 2-5: China Life Expectancy at Birth in Years, 2010-2050

Table 2-2 : Elderly Dependency Ratio in China and Other Select Countries, 2010 and 2050

DISEASE DEMOGRAPHICS

Diabetes

Cancer

Table 2-6: Top 5 Cancers Affecting Chinese Population (ranked by total number of cases), 2010-2017

Cardiovascular Disease

INFECTIOUS DISEASE THREATS

Hepatitis

HIV/AIDS

Tuberculosis

CHINESE ECONOMY

Figure 2-7: China GDP, GDP (PPP) and Health Spending, 1990-2015 (billions of $)

CHAPTER THREE: CLINICAL LABORATORY STRUCTURE IN CHINA

CLINICAL LABORATORY TESTS

Test Types

Table 3-1 : Types of IVD and Clinical Laboratory Tests, 2018

Venues for Test Usage

Figure 3-1: Utilization of Beds in Medical Institutions: China’s Average Length of Stay is Increasing Slightly, 1985-2016

Figure 3-2: Number of Visits and Admissions to Hospital Institutions in China Annually, 2015

Urban vs. Rural IVD Market

Table 3-2: China In Vitro Diagnostic Reagent Sales by Urban/Rural Environment, 2017

Figure 3-3: Province-level Administrative Divisions of China

Table 3-3: Per Capita IVD Expenditures by China Province/Region, 2017 (Guangdon, Shangdon, Henan

Sichuan, Jiangsu, Hebei, Hunan, Anhui, Hubei, Zhejiang, Others)

Figure 3-4: China IVD Market by Province/Region

CHINESE HEALTHCARE REFORM AND HOSPITAL INFRASTRUCTURE

CHINA REGULATION AND MEDICAL DEVICE POLICY CHALLENGES

Distribution in China

Medical Device Regulation Overview: China

CHAPTER FOUR: IVD MARKETS IN CHINA

MARKET INTRODUCTION AND SUMMARY

Table 4-1: China In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Infectious Disease Immunoassays, Other Immunoassays, Blood Bank Screening, POC Glucose, POC Other, ID/AST, Microbiology Molecular, PT/INR Lab, Blood Group/Typing, Blood Type Molecular, HPV, CTC, Others)

Figure 4-1: China In Vitro Diagnostic Sales by Market Segment, 2017-2022 ($ millions)

Figure 4-2: China In Vitro Diagnostic Sales by Market Segment, 2017 Market Distribution (%)

CLINICAL CHEMISTRY

Figure 4-3: China – Clinical Chemistry IVD Market, 2017-2022

Table 4-2: China – Clinical Chemistry IVD Market Distribution, 2017-2022 (%)

Figure 4-4: China – Clinical Chemistry IVD Market Value by Segment, 2017 vs. 2022

POINT-OF-CARE (POC) TESTING

Figure 4-5: China – Point-of-Care IVD Market, 2017-2022

Table 4-3: China – Point-of-Care IVD Market Distribution, 2017-2022 (%)

Figure 4-6: China – Point-of-Care IVD Market Value by Segment, 2017 vs. 2022

IMMUNOASSAYS

Figure 4-7: China – Immunoassay IVD Market, 2017-2022

Table 4-4: China – Immunoassay IVD Market Distribution, 2017-2022 (%)

Figure 4-8: China – Immunoassay IVD Market Value by Segment, 2017 vs. 2022

MOLECULAR ASSAYS

Figure 4-9: China – Molecular Assay IVD Market, 2017-2022

Table 4-5: China – Molecular Assay IVD Market Distribution, 2017-2022 (%)

Figure 4-10: China – Molecular Assay IVD Market Value by Segment, 2017 vs. 2022

Table 4-6: HIV Statistics in China, 2016

HEMATOLOGY

Figure 4-11: China – Hematology IVD Market, 2017-2022

COAGULATION

Figure 4-12: China – Coagulation IVD Market, 2017-2022

MICROBIOLOGY

Table 4-7: China Infectious Disease Classification Tier, December 2017 Impact

Figure 4-13: China – Microbiology IVD Market, 2017-2022

Table 4-8: China – Microbiology IVD Market Distribution, 2017-2022 (%)

Figure 4-14: China – Microbiology IVD Market Value by Segment, 2017 vs. 2022

TESTS USED IN BLOOD BANKING

Figure 4-15: China – Blood Bank Test IVD Market, 2017-2022

Table 4-9: Prevalence of Transfusion-transmissible Infections in Blood Donations (Median, Interquartile range (IQR), by Income Group

HISTOLOGY AND CYTOLOGY

Figure 4-16: China – Histology/Cytology IVD Market, 2017-2022

Table 4-10: China – Histology/Cytology IVD Market Distribution, 2017-2022 (%)

Figure 4-17: China – Histology/Cytology IVD Market Value by Segment, 2017 vs. 2022

PRENATAL AND GENETIC TEST SERVICES

CHAPTER FIVE: COMPANY ACTIVITY IN CHINA

CHINA IVD MARKET PARTICIPANT OVERVIEW

ABBOTT LABORATORIES

ARKRAY

BECTON, DICKINSON & CO.

BIOMÉRIEUX, INC.

BIO-RAD LABORATORIES, INC.

DANAHER CORP.

HOLOGIC, INC.

HORIBA MEDICAL

INSTRUMENTATION LABORATORY

LABORATORY CORPORATION OF AMERICA

LUMINEX CORPORATION

MEDMIRA

MINDRAY MEDICAL INTERNATIONAL, LTD.

MYRIAD GENETICS

ORTHO CLINICAL DIAGNOSTICS

PERKINELMER

PROMEGA CORPORATION

QIAGEN N.V.

ROCHE

SHANGHAI KEHUA BIO-ENGINEERING

SIEMENS AG

SYSMEX CORP.

THERMO FISHER SCIENTIFIC

APPENDIX: SOURCES OF INFORMATION

 

    30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025 (June 2025 Update)
    June 25, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    June 24, 2025
    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025

Related products

  • Placeholder image

    Molecular Imaging Agents and Systems – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00
  • Placeholder image

    The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products

    $3,000.00 – $6,000.00
  • Placeholder image

    U.S. Market for Molecular Diagnostics, 2nd Edition

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious...Next Generation Sequencing Market by Product Type (Instrumentation, Consumables,...
Scroll to top